Weekly Cetuximab and Gemcitabine plus Cisplatin as Salvage Therapy for Unresectable Non-Small Cell Lung Cancer

Publisher： Karger

E-ISSN： 2296-5262|32|11|685-686

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.11, 2009-10, pp. : 685-686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase II Randomized Study Comparing the Toxicity Profile of Gemcitabine plus Cisplatin with Gemcitabine plus Oral Etoposide in the Treatment of Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 485-492

Karger

Access to resources Recommend Favorite

Pretreatment Pokemon Level as a Predictor of Response to Cisplatin and Paclitaxel in Patients with Unresectable Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 38, Iss. 10, 2015-0 ,pp. : 496-502

Karger

Access to resources Recommend Favorite

Cisplatin-Docetaxel Induction plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer Patients: A Phase II Trial

By  

Oncology, Vol. 83, Iss. 6, 2012-09 ,pp. : 321-328

Karger

Access to resources Recommend Favorite

Chemoradiotherapy in Locally Advanced, Unresectable Non-Small Cell Lung Cancer

By  

Reviews on Recent Clinical Trials, Vol. 4, Iss. 2, 2009-05 ,pp. : 110-121

Bentham Science Publishers

Access to resources Recommend Favorite

Taxol plus Gemcitabine and Vinorelbine Given Every Other Week in Advanced Chemo-Naïve Non-Small Cell Lung Cancer Patients

By  

Oncology, Vol. 65, Iss. 4, 2004-01 ,pp. : 378-379

Karger

Access to resources Recommend Favorite